Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs.
Journal: Radiation research
Published: March 25, 2026
ATM interaction with GRP94 modulates oncogenic receptor expression and signaling and microglial activation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 19, 2025
Enhanced Response to Radiopharmaceutical Therapy in Preclinical Tumor Models with XRD-0394, a Dual Inhibitor of ATM Kinase and DNA-PKcs.
Journal: Radiation research
Published: September 23, 2025
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors.
Journal: Molecular cancer therapeutics
Published: December 15, 2023
Participation of ATM, SMG1, and DDX5 in a DNA Damage-Induced Alternative Splicing Pathway.
Journal: Radiation research
Published: December 09, 2022
ATM Regulation of the Cohesin Complex Is Required for Repression of DNA Replication and Transcription in the Vicinity of DNA Double-Strand Breaks.
Journal: Molecular cancer research : MCR
Published: May 20, 2022
Impaired endoplasmic reticulum-mitochondrial signaling in ataxia-telangiectasia.
Journal: iScience
Published: June 15, 2020
Retrospective Diagnosis of Ataxia-Telangiectasia in an Adolescent Patient With a Remote History of T-Cell Leukemia.
Journal: Journal of pediatric hematology/oncology
Published: November 20, 2019
Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness.
Journal: Diabetology & metabolic syndrome
Published: April 05, 2019
Self-inflicted DNA double-strand breaks sustain tumorigenicity and stemness of cancer cells.
Journal: Cell research
Published: January 19, 2017
Last Updated: 09/26/2026